welcome to oneFAPvoice- a positively charged Familial Adenomatous Polyposis community.
- join today!
Coxib-inhibition of Duodenal Polyp Growth in FAP
study id #: NCT00844727
condition: Duodenal Polyposis
Preliminary data indicate a protective effect on the development of duodenal polyps by coxib treatment. The hypothesis of the present study is that normal therapy doses of rofecoxib for 1 year would stop or reverse the development of premalignant adenomatous lesions in the duodenal mucosa of FAP patients.
start date: September 2003
estimated completion: April 2004
last updated: July 6, 2011
phase of development: Phase 2, Phase 3
size / enrollment: 38
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
- FAP patient with previous colectomy and confirmed polyposis
- NSAID hypersensitivity
expertly curated content related to this topic
The Natural History of Familial Adenomatous Polyposis Syndrome: A 24 Year Review of a Single Center Experience in Sc...PURPOSE : Understanding the natural hist...
Study provides better understanding of sequence of genetic events in colorectal cancer premalignancyWhole-exome sequencing of both colorecta...
Papillary Thyroid Carcinoma Associated with Familial Adenomatous Polyposis: Molecular Analysis of Pathogenesis in a ...We found a case of a papillary thyroid c...
Do NSAIDs Suppress Polyps in MUTYH-Associated Polyposis? A Case ReportPoster Presentation Background: MUTY...
Hereditary Colorectal Cancer Syndromes and Genetic TestingColorectal cancer (CRC) is a leading cau...
New Combination Therapy Can Benefit Metastatic Colon CancerNew Combination Therapy Can Benefit Meta...
Guide to Fighting Colon Polyps: How to Prevent Colon Polyps Naturally With FoodFrom garlic and turmeric to foods that c...